Sérgio Veloso Brant Pinheiro

Sérgio Veloso Brant Pinheiro

Auto-generated profile, based on publicly available information

Sérgio Veloso Brant Pinheiro

Universidade Federal de Minas Gerais Faculdade de Medicina

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SPSérgio Veloso Brant Pinheiro
Sérgio Veloso Brant Pinheiro
VFVictor Buchini de Freitas
Victor Buchini de Freitas
GCGustavo Valverde de Castro
Gustavo Valverde de Castro
BMBeatriz Cronemberger Rufino Madeiro
Beatriz Cronemberger Rufino Madeiro
SAStanley Almeida de Araújo
Stanley Almeida de Araújo
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
Background: Acute post-streptococcal glomerulonephritis (APSGN) is an immune- complex (ICs) mediated glomerular disease triggered by group A β-hemolytic streptococcus (GAS) or Streptococcus pyogenes infections. APSGN represents a major cause of acquired kidney injury in children. Methods: This non-systematic review summarizes recent evidence on APSGN. We discuss the epidemiology, pathogenesis, clinical and laboratory findings, histopathology, treatment and prognosis of the disease. Results: The median APSGN incidence in children in developing countries is estimated at 24.3/100,000 per year, compared with 6.2/100,000 per year in developed countries. Nephritis-associated plasmin receptor, identified as glyceraldehyde-3-phosphate dehydrogenase, and the cationic cysteine proteinase streptococcal pyrogenic exotoxin B are thought to be two leading streptococcal antigens involved in the pathogenesis of APSGN, which activate the complement system, mainly via the alternative but also the lectin pathway. This process is critical for the generation of inflammation by the ICs deposited in the glomerulus. The classic phenotype is an acute diffuse proliferative glomerulonephritis leading to features of the nephritic syndrome, including hematuria, oliguria, hypertension and edema. The histopathology shows that the glomeruli are diffusely affected, mostly presenting enlarged glomerular tuffs due to hypercellularity. Proliferative endothelial and mesangial cells and inflammation have also been observed. APSGN frequently has spontaneous recovery. There is no specific therapy, but its morbidity and mortality are drastically reduced by the prevention and/or treatment of complications. Conclusion: Despite recent advances, the pathogenesis of APSGN is not fully understood. There is no specific treatment for APSGN. The prognosis is generally good. However, some cases may evolve into chronic kidney disease.

1 November 2022 in Current Pediatric Reviews
Verified
Journal Article
Closed access
PDF file
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
RFRoberta da Silva Filha
Roberta da Silva Filha
KBKassia Burini
Kassia Burini
LPLaura Gregório Pires
Laura Gregório Pires
SPSérgio Veloso Brant Pinheiro
Sérgio Veloso Brant Pinheiro
Background: Idiopathic or Primary Nephrotic Syndrome (INS) is a common glomerular disease in pediatric population, characterized by proteinuria, edema and hypoalbuminemia with var-iable findings in renal histopathology.Objective: This review aims to summarize current data on the etiopathogenesis diagnosis, protocols of treatment and potential therapeutic advances in INS.Methods: This narrative review searched for articles on histopathology, physiopathology, genetic causes, diagnosis and treatment of INS in pediatric patients. The databases evaluated were PubMed and Scopus.Results: INS is caused by an alteration in the permeability of the glomerular filtration barrier with unknown etiology. There are several gaps in the etiopathogenesis, response to treatment and clinical course of INS that justify further investigation. Novel advances include the recent understanding of the role of podocytes in INS and the identification of genes associated with the disease. The role of immune system cells and molecules has also been investigated. The diagnosis relies on clinical find-ings, laboratory exams and renal histology for selected cases. The treatment is primarily based on steroids administration. In case of failure, other medications should be tried. Recent studies have al-so searched for novel biomarkers for diagnosis and alternative therapeutic approaches.Conclusion: The therapeutic response to corticosteroids still remains the main predictive factor for the prognosis of the disease. Genetic and pharmacogenomics tools may allow the identification of cases not responsive to immunosuppressive medications.

1 May 2019 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
DMDaniella Reis Barbosa Martelli
Daniella Reis Barbosa Martelli
MOMARIA CHRISTINA Christina lopes Araújo OLIVEIRA
MARIA CHRISTINA Christina lopes Araújo OLIVEIRA
SPSergio Veloso Pinheiro
Sergio Veloso Pinheiro
MSMaria Luiza Santos
Maria Luiza Santos
VDVeronica Dias
Veronica Dias
EOEduardo Oliveira
Eduardo Oliveira
SUMMARY BACKGROUND. This study aimed to evaluate the scientific production of researchers in the field of Medicine who receive a productivity grant from the CNPq. METHODS: The curriculum Lattes of 542 researchers with active grants from 2012 to 2014 were included in the analysis. Grants categories/levels were stratified into three groups according to the CNPq database (1A-B, 1C-D, and 2). RESULTS. There was a predominance of grants in category 2. During their academic career, Medicine researchers published 76512 articles, with a median of 119 articles per researcher (IQ, interquartile range, 77 to 174). Among the 76512 articles, 36584 (47.8%) were indexed in the Web of Science (WoS database). Researchers in Medicine were cited 643159 times in the WoS database, with a median of 754 citations (IQ, 356 to 1447). There were significant differences among the categories of grants concerning the number of citations in WoS (P <0.001). There was a significant difference in the number of times researchers were cited according to the specialty included in Medicine area. (P < 0.001). CONCLUSION. Strategies to improve the scientific output qualitatively possibly can be enhanced by the knowledge of the profile of researchers in the field of Medicine.

17 June 2022 in Current Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva
AAAlessandra Aguiar dos Anjos
Alessandra Aguiar dos Anjos
IPIsadora Tucci de Paiva
Isadora Tucci de Paiva
GLGiovanna Letícia Simões Lima
Giovanna Letícia Simões Lima
RFRoberta da Silva Filha
Roberta da Silva Filha
SPSérgio Veloso Brant Pinheiro
Sérgio Veloso Brant Pinheiro
Idiopathic Nephrotic Syndrome (INS) is the most frequent etiology of glomerulopathy in pediatric patients and one of the most common causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in this population. In this review, we aimed to summarize evidence on the pathophysiological role and therapeutic potential of the Renin-Angiotensin System (RAS) molecules for the control of proteinuria and for delaying the onset of CKD in patients with INS. This is a narrative review in which the databases PubMed, Web of Science, and Sci- ELO were searched for articles about INS and RAS. We selected articles that evaluated the pathophysiological role of RAS and the effects of the alternative RAS axis as a potential therapy for INS. Several studies using rodent models of nephropathies showed that the treatment with activators of the Angiotensin-Converting Enzyme 2 (ACE2) and with Mas receptor agonists reduces proteinuria and improves kidney tissue damage. Another recent paper showed that the reduction of urinary ACE2 levels in children with INS correlates with proteinuria and higher concentrations of inflammatory cytokines, although data with pediatric patients are still limited. The molecules of the alternative RAS axis comprise a wide spectrum, not yet fully explored, of potential pharmacological targets for kidney diseases. The effects of ACE2 activators and receptor Mas agonists show promising results that can be useful for nephropathies including INS.

28 August 2026 in Research Square
Verified
Preprint
Open access
PDF file
CRCelina de Faria Rezende
Celina de Faria Rezende
MCMariângela Leal Cherchiglia
Mariângela Leal Cherchiglia
HRHugo André da Rocha
Hugo André da Rocha
MSMarcelo Ferraz de Oliveira Souto
Marcelo Ferraz de Oliveira Souto
MPMaria Goretti Moreira Guimarães Penido
Maria Goretti Moreira Guimarães Penido
SPSergio Veloso Brant Pinheiro
Sergio Veloso Brant Pinheiro
Background Chronic kidney disease affects approximately 1–3% of children and adolescents, with kidney replacement therapy (KRT) indicated for end stage kidney disease (ESKD). However, outcomes of transplanted patients remain poorly understood. This study aimed to describe clinical characteristics and factors associated with kidney transplantation and mortality in Brazilian pediatric patients with ESKD between 2002 and 2014. Methods This retrospective cohort study used secondary data from the National Database on Kidney Replacement Therapies. The study included pediatric patients under KRT with a minimum follow-up of six months. The outcomes assessed were kidney transplantation and death. Results A total of 7,544 patients aged 0 to 17 years and 11 months were included; 53.8% were male, 38.9% were White, 68.7% were adolescents, and 47.6% had congenital anomalies of the kidney and urinary tract. Initial treatment modalities were hemodialysis (51.7%), peritoneal dialysis (26.9%), immunosuppressive medications (11.4%), and kidney transplantation (9.7%). Kidney transplantation, particularly preemptive transplantation (hazard ratio [HR] = 0.07; 95% confidence interval [95% CI] = 0.06–0.09), significantly reduced the risk of death. Other factors associated with increased survival included male sex (HR = 0.77; 95% CI = 0.66–0.90), living in the Southern region of Brazil (HR = 1.44; 95% CI = 1.24–1.67), and receiving treatment outside the region of residence (HR = 1.25; 95% CI = 1.08–1.44). Dialysis treatment was associated with higher risk of death (HR = 1.52; 95% CI = 1.32–1.75). Conclusions The findings underscore the importance of early, preferably preemptive, kidney transplantation in pediatric patients with ESKD to minimize dialysis duration and improve survival.